Nanollose Ltd (ASX:NC6) 2018 AGM & Presentation
Nanollose Limited (ASX:NC6) reminds shareholders that its 2018 Annual General Meeting will be held at 1:00pm WST on Monday, 29 October 2018 at its registered office.
Companies in the News
Biotech
Nanollose Ltd (ASX:NC6) to Access Additional R&D Rebates on Overseas Expenditure
Nanollose Limited (ASX:NC6) is pleased to announce that it has obtained favourable findings from the Department of Industry, Innovation and Science which will enable the Company to claim tax rebates on certain overseas research and development expenditure up to $1.419 million over the next three years.
Queensland Bauxite Ltd (ASX:QBL) Strategic Collaboration and Supply Agreement Signed with Canadian Licensed Producer
The Board of Queensland Bauxite Limited (ASX:QBL) is very pleased to announce a materially strategic transaction, that its soon to be wholly owned subsidiary Medcan Australia, has entered into a Strategic Collaboration and Supply Agreement Signed with an established Canadian Licensed Producer of Medical Cannabis.
Regeneus Ltd (ASX:RGS) Quarterly Results for the Period Ended 30 September 2018
Regeneus Ltd (ASX:RGS) provides the Company's quarterly results for the period ended 30 September 2018.
Anatara Lifesciences Ltd (ASX:ANR) Formation of Product Development Advisory Board
Anatara Lifesciences (ASX:ANR), a company focused on commercialising innovative products for gut health, is pleased to announce the formation of its Product Development Advisory Board. The Advisory Board consists of five key external experts: Dr Rebecca Burgell, Dr Jakob Begun, Prof Barry Campbell, Assoc Prof Simon Keely and Prof Peter Gibson, who will serve as the Chairman.
Queensland Bauxite Ltd (ASX:QBL) Annual Report to Shareholders
Queensland Bauxite Ltd (ASX:QBL) provides the Company's Annual Report to shareholders.
Queensland Bauxite Ltd (ASX:QBL) JV with Leading Israeli Medicinal Cannabis Company Pharmocann
The Board of Queensland Bauxite Limited (ASX:QBL) is very pleased to announce a materially strategic transaction, that its soon to be wholly owned subsidiary Medcan Australia, has entered into a memorandum of understanding with top Israeli medicinal cannabis company Pharmocann.
◂Previous Page
Biotech Next Page▸
Banking & Finance
- Locksley Resources Limited (ASX:LKY) Qualifies for Trading on U.S. OTCQX Market
- Resolution Minerals Ltd (ASX:RML) OTCQB Listing Successfully Completed
- VIDEO: Lion Selection Group Ltd (ASX:LSX) CEO Hedley Widdup and Sean Russo Talk at the Australian Gold Conference 2024
- VIDEO: The Australian Gold Conference 2024 - Education Evening with Expert Panel
- Lithium Universe Ltd (ASX:LU7) Finalises Frankfurt and US OTC Listing
- ISX Financial Reports Strong Q2 2024 Results, Highlighting Robust Growth and Innovation
Oil Gas & Energy
- Ellis Martin Report: Desert Mountain Energy Corp. (CVE:DME): Hydrogen, Helium-3, The Next Frontier of Energy Storage - A Long Form Interview with CEO Robert Rohlfing
- Deep Yellow Limited (ASX:DYL) Drilling at S-Bend Prospect Confirms Uranium Extensions
- Ellis Martin Report: Desert Mountain Energy Corp.'s (CVE:DME) Strategic Leap: Joining the Pentagon's Directed Energy Consortium
- Ellis Martin Report: Conversation with Gary Hanna, President of Prairie Operating Co. (NASDAQ:PROP)
- State Gas Limited (ASX:GAS) Annual Report to Shareholders
- Central Petroleum Limited (ASX:CTP) Investor Presentation - FY2025 Annual Results
Life Sciences
- Proteomics International Laboratories Ltd (ASX:PIQ) Collaboration expanded to advance Endometriosis blood test
- Proteomics International Laboratories Ltd (ASX:PIQ) Appointment of Director
- Proteomics International Laboratories Ltd (ASX:PIQ) Appointment of Company Secretary
- BPH Energy Limited (ASX:BPH) PEP 11 Update
- BPH Energy Limited (ASX:BPH) PEP 11 Update
- Ellis Martin Report: Dr. Amie Phinney of Defence Therapeutics Inc. (CNSX:DTC) on the Accum(TM) Platform
Social Media
